Less Invasive Lymph Node Surgery in Breast Cancer: What Researchers Are Studying


Breast cancer surgery continues to evolve not only in how cancer is treated, but also in how the effects of treatment may be reduced. A recent review examines endoscopic axillary lymphadenectomy, a minimally invasive approach being studied for selected patients who still require the removal of lymph nodes from the underarm area.
Bram Goldstein, Ph.D., President and Senior Clinical Fellow of the Women’s Cancer Research Foundation, provides clinical context on the technique, its potential benefits, and the research still needed.
Axillary lymphadenectomy (a procedure used to evaluate whether cancer has spread beyond the primary tumor) for breast cancer remains a necessary surgical procedure in selected cases. Associated morbidity includes lymphedema (swelling arising from the lymph nodes), pain, and sensory or mobility impairments.
Within the realm of breast cancer innovation, minimally invasive surgery has extended to the axilla (the area under the armpit or underarm) through endoscopic axillary lymphadenectomy (EALND). A recent review article from Cancers sought to summarize the evolution of the technique, clinical outcomes, and current evidence.
Available studies suggest that EALND may offer benefits in terms of postoperative morbidity while maintaining adequate surgical outcomes. However, due to the limited number of high-quality studies and the ongoing evolution of this technique, further well-designed research, including studies with longer follow-up, is needed to provide more robust evidence regarding its clinical and oncological outcomes.
Why This Breast Cancer Research Matters
Advances in cancer care are not limited to new medications. They also include improving surgical approaches to reduce complications and protect quality of life.
The available evidence surrounding endoscopic axillary lymphadenectomy is encouraging, but it remains limited. Continued research with well-designed studies and longer follow-up will help determine the role this minimally invasive approach may have in breast cancer surgery.
Read the original article: Endoscopic Axillary Lymphadenectomy in Breast Cancer: Evolution, Current Evidence, and Future Perspectives
Medical note: This article is intended for educational purposes only and does not provide medical advice, diagnosis, or individualized screening or treatment recommendations. Please consult a qualified healthcare professional about personal health concerns.





Comments